Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study

Guardado en:
Detalles Bibliográficos
Autores principales: Pankaj Jariwala, Kartik Jadhav
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Surgery
RD1-811
Diseases of the circulatory (Cardiovascular) system
RC666-701
Acceso en línea:https://doaj.org/article/078ac2117a414bc59d6ea8d42501fd27
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:078ac2117a414bc59d6ea8d42501fd27
record_format dspace
spelling oai:doaj.org-article:078ac2117a414bc59d6ea8d42501fd272021-12-02T04:58:52ZSafety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study0019-483210.1016/j.ihj.2021.11.175https://doaj.org/article/078ac2117a414bc59d6ea8d42501fd272021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0019483221004387https://doaj.org/toc/0019-4832Pankaj JariwalaKartik JadhavElsevierarticleSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENIndian Heart Journal, Vol 73, Iss , Pp S86- (2021)
institution DOAJ
collection DOAJ
language EN
topic Surgery
RD1-811
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Surgery
RD1-811
Diseases of the circulatory (Cardiovascular) system
RC666-701
Pankaj Jariwala
Kartik Jadhav
Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
format article
author Pankaj Jariwala
Kartik Jadhav
author_facet Pankaj Jariwala
Kartik Jadhav
author_sort Pankaj Jariwala
title Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
title_short Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
title_full Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
title_fullStr Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
title_full_unstemmed Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
title_sort safety and effectiveness of angiotensin receptor-neprilysin inhibitors (arni) in patients with heart failure with preserved ejection fraction (hfpef) – ‘arni-preserved’ study
publisher Elsevier
publishDate 2021
url https://doaj.org/article/078ac2117a414bc59d6ea8d42501fd27
work_keys_str_mv AT pankajjariwala safetyandeffectivenessofangiotensinreceptorneprilysininhibitorsarniinpatientswithheartfailurewithpreservedejectionfractionhfpefarnipreservedstudy
AT kartikjadhav safetyandeffectivenessofangiotensinreceptorneprilysininhibitorsarniinpatientswithheartfailurewithpreservedejectionfractionhfpefarnipreservedstudy
_version_ 1718400871315800064

Ejemplares similares